MA49464A - Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants - Google Patents

Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants

Info

Publication number
MA49464A
MA49464A MA049464A MA49464A MA49464A MA 49464 A MA49464 A MA 49464A MA 049464 A MA049464 A MA 049464A MA 49464 A MA49464 A MA 49464A MA 49464 A MA49464 A MA 49464A
Authority
MA
Morocco
Prior art keywords
associations
corresponding processes
targeted drug
new compositions
drug rescue
Prior art date
Application number
MA049464A
Other languages
English (en)
Inventor
Anton Bespalov
Hans J Moebius
Sreenivasarao Vepachedu
Original Assignee
Exciva GmbH
Sreenivasarao Vepachedu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TW106129169A external-priority patent/TW201815387A/zh
Application filed by Exciva GmbH, Sreenivasarao Vepachedu filed Critical Exciva GmbH
Publication of MA49464A publication Critical patent/MA49464A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MA049464A 2017-05-04 2018-05-03 Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants MA49464A (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762501696P 2017-05-04 2017-05-04
TW106129169A TW201815387A (zh) 2016-08-26 2017-08-28 組成物及其方法
US201862634162P 2018-02-22 2018-02-22
US201862636099P 2018-02-27 2018-02-27
US201862635554P 2018-02-27 2018-02-27
US201862636171P 2018-02-28 2018-02-28

Publications (1)

Publication Number Publication Date
MA49464A true MA49464A (fr) 2020-04-29

Family

ID=65431106

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049464A MA49464A (fr) 2017-05-04 2018-05-03 Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants

Country Status (13)

Country Link
EP (1) EP3618819A4 (fr)
JP (2) JP2020518617A (fr)
KR (2) KR20200062078A (fr)
CN (1) CN110831584B (fr)
AU (2) AU2018261654A1 (fr)
BR (1) BR112019022902A2 (fr)
CA (2) CA3138116A1 (fr)
IL (1) IL270326B2 (fr)
MA (1) MA49464A (fr)
RU (1) RU2760558C9 (fr)
TW (1) TWI787260B (fr)
WO (1) WO2018204713A1 (fr)
ZA (1) ZA201908006B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020190971A1 (fr) * 2019-03-18 2020-09-24 Avanir Pharmaceuticals, Inc. Méthodes de traitement de symptômes négatifs de la schizophrénie à l'aide de dextrométhorphane deutéré et de quinidine
MX2022014605A (es) 2020-05-19 2022-12-16 Cybin Irl Ltd Derivados de triptamina deuterada y metodos de uso.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241065A (en) * 1979-07-02 1980-12-23 E. I. Du Pont De Nemours And Company Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both
US4950658A (en) * 1988-12-06 1990-08-21 Board Of Trustees Of Southern Illinois Univ. Method of medical treatment of Alzheimer's disease
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
TWI326214B (en) * 2002-07-17 2010-06-21 Avanir Pharmaceuticals Inc Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
US20070099947A1 (en) * 2005-11-03 2007-05-03 Alkermes, Inc. Methods and compositions for the treatment of brain reward system disorders by combination therapy
RU2497819C2 (ru) * 2007-05-21 2013-11-10 Ривайва Фармасьютикалс, Инк. Композиции, синтез и способы применения атипичных нейролептиков на основе хинолина
US8017623B2 (en) * 2008-07-03 2011-09-13 Trinity Laboratories, Inc. Dextromethorphan hydrochloride
US9737531B2 (en) * 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CA2903757A1 (fr) * 2013-03-07 2014-09-12 Mindlab LLC Combinaison de medicament antidouleur et ses utilisations
EP2972329A2 (fr) * 2013-03-15 2016-01-20 Kinemed, Inc. Biomarqueurs
CN109890371A (zh) * 2016-08-26 2019-06-14 斯瑞尼瓦萨饶·韦帕切杜 组合物及其方法

Also Published As

Publication number Publication date
KR102444803B1 (ko) 2022-09-19
RU2760558C9 (ru) 2022-02-22
EP3618819A1 (fr) 2020-03-11
WO2018204713A1 (fr) 2018-11-08
CA3138116A1 (fr) 2018-11-08
IL270326B (en) 2022-10-01
TW201842902A (zh) 2018-12-16
AU2021215274B2 (en) 2022-11-03
EP3618819A4 (fr) 2021-01-20
CN110831584B (zh) 2023-03-10
AU2021215274A1 (en) 2021-09-02
KR20210130827A (ko) 2021-11-01
TWI787260B (zh) 2022-12-21
ZA201908006B (en) 2021-04-28
IL270326A (fr) 2018-05-03
JP2020518617A (ja) 2020-06-25
BR112019022902A2 (pt) 2020-05-19
CA3062452C (fr) 2023-10-24
AU2018261654A1 (en) 2019-11-14
IL270326B2 (en) 2023-02-01
RU2760558C2 (ru) 2021-11-29
JP2023143940A (ja) 2023-10-06
RU2019137004A (ru) 2021-06-04
CN110831584A (zh) 2020-02-21
KR20200062078A (ko) 2020-06-03
CA3062452A1 (fr) 2018-11-08
RU2019137004A3 (fr) 2021-06-04

Similar Documents

Publication Publication Date Title
MA45188A (fr) Oligonucléotides, compositions et méthodes associées
CL2018000813A1 (es) Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso.
BR112018003110A2 (pt) nanopartículas terapêuticas compreendendo um agente terapêutico e métodos de fabricação e uso dos mesmos
DK3258939T3 (da) Neuroaktive steroider, sammensætninger og anvendelser heraf
DK3319434T3 (da) Herbicidsammensætning, der omfatter cinmethylin og pethoxamid
DK3705488T3 (da) Neuroaktive steroider, sammensætninger og anvendelse heraf
DK3580561T3 (da) Hla-baserede metoder, sammensætninger og anvendelse heraf
BR112016018521A2 (pt) composição, e, kit.
CL2018000565A1 (es) Compuestos derivados de piridinona dicarboxamida, inhibidores de bromodominio; composicion farmaceutica; combinacion farmaceutica; utiles en el tratamiento de enfermedades autoinmunitarias, inflamatorias, virales y cancer, entre otras.
MA47019A (fr) Agents, utilisations et procédés
MA49633A (fr) Agents, utilisations et procédés de traitement
MA47516A (fr) Composition pharmaceutique
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
MA49464A (fr) Targeted drug rescue avec de nouvelles compositions, associations et procédés correspondants
CL2020000973A1 (es) Composiciones y procedimientos para el tratamiento de linfoma difuso de celulas b grandes.
IL265821A (en) Urea derivatives, preparations containing them and their uses
PT3568419T (pt) Polibutadienos, preparação e utilização dos mesmos
DK3424500T3 (da) Farmaceutisk sammensætning, der omfatter famitinib
MA56458A (fr) Compositions de macitentan comprimées, procédés et utilisations de celles-ci
IT201700119847A1 (it) Struttura di ventilatore con dispositivo di trattamento dell'aria.
TH1601003241A (th) การใช้ของอนุพันธ์เบนซิมิดาโซล-โปรลีน
RU2014107124A (ru) Взрывчатый состав на основе гексогена
IT201700028709A1 (it) Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti
TH1701007762A (th) อนุพันธ์ 2,3-ไดไฮโดร-4h-1,3-เบนซอกซาซิน-4-โอน ที่เป็นตัวควบคุมของโคลิเนอร์จิคมัสคารินิค m1 รีเซพเตอร์
TH1501004072A (th) สารตัวยาแบบผสมผสานซึ่งประกอบรวมด้วยเฟนิเลฟรีนและพาราเซตามอล